Two studies carried out by researchers from the GIGA CRC IVI at ULiège could provide new insights into how our brains work.
A multidisciplinary research team led by ULiège and CHU Liège has uncovered evidence of increased neuronal connectivity in the brains of entrepreneurs, which may contribute to distinct cognitive attributes.
Sophie obtained a "young researcher" funding of 60.000€ for her project on the effect of alcohol on the brain of adolescents and Pierre a credit of 120.000€ for his projects on the use of the 7 Tesla MRI in neurological research.
Fabienne Collette (Covid long) and Gilles Vandewalle (Alzheimer) spoke on RTBF to explain their respective projects.
TAME and Rebone will enable PhD students to be supervised on ambitious themes over the next three years.
Three groups of researchers from the University of Liège (ULiège) have been awarded a grant from the Alzheimer Research Foundation totalling €950,000 for their research into Alzheimer's disease.
The COST program is one of the broadest frameworks for scientific cooperation in Europe and an interesting mechanism for the coordination and dissemination of the European research effort.
Des chercheurs du CRC ont participé à une étude observant l’impact d’un entraînement à la méditation de 18 mois sur certaines structures cérébrales impliquées dans la régulation de l’attention et des émotions,chez des personnes de plus de 65 ans.
Study conducted by ULiège GIGA CRC In vivo Imanging researchers shows that "Mind blanking" (MB) is a distinct mental state linked to a recurrent brain profile of globally positive connectivity during ongoing mentation.
Latest generation tools, financed by the Fondation contre le Cancer, that will accelerate the use of preclinical molecular imaging in vivo.
Congratulations to all researchers obtaining a new FNRS mandate !
Research conducted at the GIGA could make it possible to detect individuals at risk of developing Alzheimer's disease at a very early stage and, in the long term, to take better care of them to prevent or delay the disease.